LARVOL, a providesr of SaaS solutions to support the data and intelligence needs of the pharmaceutical and biotech industry, announced on Tuesday that it has appointed Mark Lagunowich as vice president, Global Sales.
With more that 30 years of experience in the life science industry, Lagunowich most recently led the Americas Life Science Sales Team for Clarivate Analytics.
Previously, Lagunowich worked as Global VP of Sales at Sparta Systems for eight years, selling a wide variety of business solutions to pharmaceutical, medical device, and clinical research (CRO) companies.
Lagunowich's appointment adds to several important new hires for LARVOL, including HR and Marketing leadership roles, as the company prepares to launch additional oncology-focused solutions in 2021. These include VIEW, a social listening platform aimed at capturing the conversations of oncology opinion leaders on Twitter, which will launch at ScaleUp 360 in April, along with CLIN, a complete database of immuno-oncology clinical trial data that will also launch in spring this year.
Inovio completes Phase II enrolment for US trail of COVID-19 vaccine candidate
US FDA Accepts US Merck's Gefapixant New Drug Application for Review
Eurofins Launches At-Home COVID-19 PCR Test kit Available Direct to Consumers
Olympus Corporation exercises call option for the acquisition of Medi-Tate Ltd, Israel
Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization
MatMaCorp's COVID-19 2SF RNA Test Effective in Detecting Variants
Minnesota Medical Technologies signs distribution agreement with Wellspect Healthcare
Non-Invasive Vagus Nerve Stimulation Enters New Stage of COVID-19 Research
Locate Bio wins FDA breakthrough device designation for the regenerative product Chondro3
CureScience Institute announces appointment of Dr Boris Reznik as member of Advisory Board
LARVOL names Mark Lagunowich as vice president, Global Sales
French researchers develop a more accurate and fast COVID-19 test